Citra Marga Nusaphala Persada (CMNP)
Jakarta Exchange · Indonesia · prices in IDR · close of 23 Oct 2026
Key indicators
| Last close | IDR 1,305.00 |
|---|---|
| 52-week range | 1,190.00 – 2,130.00 |
| Return, 1 month / 3 months | −6.1% / −3.0% |
| Return, 1 year / 3 years | +0.0% / −13.3% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 41.9% |
| Worst drawdown (1 year) | -34.4% |
| Average daily value traded | 350.81M IDR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Citra Marga Nusaphala Persada is an Indonesian infrastructure company that builds and operates toll roads, with its network concentrated in and around Jakarta. It manages toll road concessions, collects toll revenue from motorists and other road users, and takes part in developing related transport infrastructure. The company is based in Indonesia and serves the travelling public and commercial traffic using its highways, while also working with government bodies on toll road projects.
Citra Marga Nusaphala Persada trades under the code CMNP on the Jakarta Exchange in Indonesia, with its price quoted in Indonesian rupiah (IDR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Citra Marga Nusaphala Persada (CMNP) trades on the Jakarta Exchange in Indonesia. It last closed at IDR 1,305.00 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 333 of 923 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it fell 3.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Jakarta Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -8.2% | ||
| From 52-week high | -33.1% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.0% | ||
| 6-month return | -23.7% | ||
| 12-month return, skipping the last month | 6.5% | ||
| Stability (higher is calmer) | 76 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.4% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 350.81M IDR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | −6.1% |
| 3 months | −3.0% |
| 6 months | −23.7% |
| 1 year | +0.0% |
| 3 years | −13.3% |
| 5 years | −1.9% |
Signals
| 50-day / 200-day average | 1,390.50 / 1,420.85 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 56.12 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Jakarta Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.